Skip to content
← Back to this collection

PUBLICATIONS · 9123736

The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Urology
Publication date
1997 Mar
First author
Fair WR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Fair WR
      type
      Author
    2. name
      Cookson MS
      type
      Author
    3. name
      Stroumbakis N
      type
      Author
    4. name
      Cohen D
      type
      Author
    5. name
      Aprikian AG
      type
      Author
    6. name
      Wang Y
      type
      Author
    7. name
      Russo P
      type
      Author
    8. name
      Soloway SM
      type
      Author
    9. name
      Sogani P
      type
      Author
    10. name
      Sheinfeld J
      type
      Author
    11. name
      Herr H
      type
      Author
    12. name
      Dalgabni G
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Fair WR
      type
      Author
    2. name
      Cookson MS
      type
      Author
    3. name
      Stroumbakis N
      type
      Author
    4. name
      Cohen D
      type
      Author
    5. name
      Aprikian AG
      type
      Author
    6. name
      Wang Y
      type
      Author
    7. name
      Russo P
      type
      Author
    8. name
      Soloway SM
      type
      Author
    9. name
      Sogani P
      type
      Author
    10. name
      Sheinfeld J
      type
      Author
    11. name
      Herr H
      type
      Author
    12. name
      Dalgabni G
      type
      Author
    bibliography ids
    1. nci-bib-d2f81373188ba2d4eb227813
    book metadata
    content sha256
    3ed4622f3cce0902ce8e230151749b33f8e0732b99d6840aafd30ce54b00b2cf
    document type
    citation
    dois
    1. 10.1016/s0090-4295(97)00169-6
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:9123736
    immutable id
    pubmed:9123736@3ed4622f3cce0902ce8e230151749b33f8e0732b99d6840aafd30ce54b00b2cf
    journal
    abbreviation
    Urology
    issn electronic
    Source null
    issn print
    0090-4295
    issue
    3A Suppl
    name
    Urology
    nlm unique id
    0366151
    pages
    46-55
    volume
    49
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      9123736
      provenance
      batch id
      629590480cca3a097fa8
      provider
      NCBI PubMed ESummary
      record sha256
      3190da2079ef5dd0e6e17436b416c8c6994d86be0beab5a2b7f7a1cb013d23ca
      response sha256
      0eb1cec7011436204408643f1cea7888e97d436038d0a09eaecfd9b32db84919
      retrieved at
      2026-09-09T23:45:26.993225+00:00
      publication date
      display
      1997 Mar
      precision
      month
      year
      1997
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Clinical Trial, Phase III
      4. Journal Article
      5. Randomized Controlled Trial
      6. Research Support, U.S. Gov't, P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/9123736/
      title
      The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.

      Preserved source evidence · Not medical advice